Safety of Biologic Therapies for the Treatment of Juvenile Idiopathic Arthritis: Results from the Spanish Registry of Adverse Events with Biologic Therapies (BIOBADASER)
14/08/2023
Bethencourt Baute JJ, Sánchez-Piedra C, Expósito Pérez L, Hernández MV, Manero J, Rosello R, Sánchez-Alonso F, Ruiz-Montesinos D, Perez Pampín E, Rodriguez-Lozano C, Campos Fernandez C, Fernández-Carballido C, Martín-Domenech R, Del Pino-Montes J, Freire M, Díaz-González F, Gomez-Reino JJ, Bustabad S
ACR 2017
Bethencourt Baute JJ, Sánchez-Piedra C, Expósito Pérez L, Hernández MV, Manero J, Rosello R, Sánchez-Alonso F, Ruiz-Montesinos D, Perez Pampín E, Rodriguez-Lozano C, Campos Fernandez C, Fernández-Carballido C, Martín-Domenech R, Del Pino-Montes J, Freire M, Díaz-González F, Gomez-Reino JJ, Bustabad S. Safety of Biologic Therapies for the Treatment of Juvenile Idiopathic Arthritis: Results from the Spanish Registry of Adverse Events with Biologic Therapies (BIOBADASER) [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/safety-of-biologic-therapies-for-the-treatment-of-juvenile-idiopathic-arthritis-results-from-the-spanish-registry-of-adverse-events-with-biologic-therapies-biobadaser/.
ttps://acrabstracts.org/abstract/safety-of-biologic-therapies-for-the-treatment-of-juvenile-idiopathic-arthritis-results-from-the-spanish-registry-of-adverse-events-with-biologic-therapies-biobadaser/